Calamos Advisors Boosts Stake in Silicon Laboratories to $1.02 Million

Calamos Advisors LLC significantly increased its investment in Silicon Laboratories, Inc. (NASDAQ:SLAB) during the second quarter of 2023, raising its stake by 77.3%. According to the firm’s recent filing with the Securities and Exchange Commission, Calamos now holds 6,917 shares of the semiconductor company, valued at approximately $1.02 million following the acquisition of an additional 3,015 shares during the quarter.

This strategic move by Calamos is part of a broader trend among institutional investors adjusting their portfolios in relation to Silicon Laboratories. For instance, Envestnet Asset Management Inc. increased its holdings by 5.0% in the first quarter, now owning 111,129 shares worth around $12.51 million. Cerity Partners LLC also expanded its position by 5.9%, bringing its total to 13,552 shares valued at $1.53 million.

Additionally, the Louisiana State Employees Retirement System raised its stake by 1.1%, now holding 9,100 shares worth $1.02 million, while Securian Asset Management Inc. increased its position by 4.2% with 2,498 shares valued at $281,000. Edgestream Partners L.P. also made headlines by acquiring a new stake valued at approximately $325,000.

Analysts Weigh In on Silicon Laboratories

Analysts have recently issued a range of price targets for Silicon Laboratories. Weiss Ratings maintained a “sell (e+)” rating in a report on Thursday, while Stifel Nicolaus revised their target from $144.00 to $160.00, assigning a “buy” rating. Conversely, Morgan Stanley lowered its target from $157.00 to $144.00, recommending an “equal weight” rating.

Barclays also adjusted their price objective, increasing it from $100.00 to $130.00 and maintaining an “equal weight” rating. Following suit, Susquehanna raised its target from $110.00 to $150.00, giving the stock a “neutral” rating. Currently, four analysts have rated the stock as a buy, three as hold, and one as sell, resulting in an average rating of “hold” and a consensus price target of $153.43, according to MarketBeat.com.

Current Stock Performance and Earnings Report

On Friday, shares of Silicon Laboratories opened at $121.89. The company has experienced a 12-month low of $82.82 and a high of $160.00, with a market capitalization of $4 billion and a price-to-earnings ratio of -37.85. The company’s 50-day moving average price stands at $132.36, while the 200-day moving average is $132.70.

Silicon Laboratories reported its quarterly earnings results on November 4, 2023, revealing earnings per share of $0.32, surpassing analysts’ expectations of $0.30 by $0.02. The company achieved revenue of $206 million, slightly exceeding consensus estimates of $205.04 million. Despite this positive performance, Silicon Laboratories reported a negative net margin of 14.88% and a negative return on equity of 7.21%. For the fourth quarter of 2025, Silicon Laboratories has projected earnings per share guidance in the range of $0.400 to $0.700.

In terms of insider trading, Senior Vice President Brandon Tolany sold 1,800 shares of Silicon Laboratories on August 29, 2023, at an average price of $133.57, amounting to a total of $240,426. Following this transaction, he retains 62,328 shares, valued at approximately $8.33 million. Over the past 90 days, insiders have sold 12,070 shares valued at $1.70 million, while company insiders maintain ownership of 1.60% of the company’s stock.

Silicon Laboratories, a fabless semiconductor company, specializes in analog-intensive mixed-signal solutions across various sectors, including the Internet of Things (IoT), smart cities, commercial applications, and connected health.